Compare BIAF & CNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
ConnectM Technology Solutions Inc is a clean energy technology and solutions provider. The company provides residential and light commercial buildings and all-electric original equipment manufacturers (OEMs) with a proprietary digital platform to accelerate the transition to solar and all-electric heating, cooling and transportation. The group makes electrification more user-friendly, affordable, precise, and socially meaningful by combining technology, data, artificial intelligence, and contemporary design. In addition to its vertically integrated service network, ConnectM offers customers a comprehensive technology stack that enables them to reduce their fossil fuel consumption, lower their energy bills, and decrease their carbon footprint.